sCD25 has been found to be a suitable serum and urine biomarker for LN in adult-onset SLE [110,111], and more recently in JSLE, correlating positively with the level of proteinuria, and the SLEDAI, renal SLEDAI, and SLICC renal activity scores, and negatively with C3 serum levels [95]. The gene discussed is C3; the disease is lobular neoplasia.